You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Cushing Disease: A Multidisciplinary Treatment Update

  • Authors: Laurence Katznelson, MD; Brooke Swearingen, MD; Nicholas Tritos, MD; Susan Cornell, PharmD, CDE; Rita Pach, RN, MSN
  • CME/CE Released: 6/26/2013
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 6/26/2014
Start Activity


Target Audience and Goal Statement

This activity is intended for endocrinologists, primary care physicians, nurses, nurse practitioners, and pharmacists.

The goal of this activity is to review the diagnosis and treatment of Cushing disease from a multidisciplinary perspective.

Upon completion of this activity, participants will be able to:

  1. Outline the rationale for a multidisciplinary approach to the diagnosis and treatment of patients with Cushing disease
  2. Review the safety and efficacy of current management strategies for patients with Cushing disease
  3. Describe the diagnostic workup for Cushing disease and the reasons why timely diagnosis and treatment are important


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Authors

  • Laurence Katznelson, MD

    Professor of Medicine and Neurosurgery, Stanford University; Medical Director, Pituitary Center, Stanford Hospital and Clinics, Stanford, California

    Disclosures

    Disclosure: Laurence Katznelson, MD, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Corcept Therapeutics Inc.; Novartis Pharmaceuticals Corporation

    Dr Katznelson does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Katznelson does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Brooke Swearingen, MD

    Associate Professor of Neurosurgery, Harvard Medical School; Associate Visiting Neurosurgeon, Massachusetts General Hospital, Boston, Massachusetts

    Disclosures

    Disclosure: Brooke Swearingen, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Novartis Pharmaceuticals Corporation
    Owns stock, stock options or bonds from: Novartis Pharmaceuticals Corporation; Pfizer Inc; Amgen Inc; Roche

    Dr Swearingen does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Swearingen does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Nicholas Tritos, MD

    Assistant Professor of Medicine, Harvard Medical School; Staff, Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts

    Disclosures

    Disclosure: Nicholas Tritos, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Corcept Therapeutics Inc; Pfizer Inc
    Received grants for clinical research from: Pfizer Inc; Ipsen

    Dr Tritos does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Tritos does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Susan Cornell, PharmD, CDE

    Associate Professor, Pharmacy Practice, Midwestern University-Chicago, Downers Grove, Illinois; Clinical Pharmacist/Certified Diabetes Educator, DuPage Community Clinic, Wheaton, Illinois

    Disclosures

    Disclosure: Susan Cornell, PharmD, CDE, has disclosed the following relevant relationships:
    Served as a speaker or member of a speakers bureau for: Johnson & Johnson Diabetes Institute

    Dr Cornell does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Cornell does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Rita Pach, RN, MSN

    Nurse, Johns Hopkins Pituitary Center, Baltimore, Maryland

    Disclosures

    Participation by Mrs Pach in the development of this product does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
    Disclosure: Rita Pach, RN, has disclosed no relevant financial relationships.

    Mrs Pach does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Mrs Pach does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Kristin M. Richardson

    Group Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Kristin M. Richardson has disclosed no relevant financial relationships.

  • David Modrak, PhD

    Freelance editor, Montville, New Jersey

    Disclosures

    Disclosure: David Modrak, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Medscape designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number 0461-0000-13-027-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME/CE

Cushing Disease: A Multidisciplinary Treatment Update

Authors: Laurence Katznelson, MD; Brooke Swearingen, MD; Nicholas Tritos, MD; Susan Cornell, PharmD, CDE; Rita Pach, RN, MSNFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME/CE Released: 6/26/2013

Valid for credit through: 6/26/2014

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Section 1. Cushing Disease: An Introduction
Dr Laurence Katznelson reviews the basics of this rare disease.
Laurence Katznelson, MD
Section 2. Surgical Approaches to Cushing Disease
Dr Brooke Swearingen reviews the surgical treatment of Cushing disease.
Brooke Swearingen, MD
Section 3. Medical Therapy for Cushing Disease
Dr Nicholas Tritos reviews medical options for the treatment of Cushing disease.
Nicholas Tritos, MD
Section 4. Cushing Disease: A Nursing Perspective
Rita Pach, RN, MSN, discusses how nurses can be part of a multidisciplinary team treating patients with Cushing disease.
Rita Pach, RN, MSN
Section 5. Medical Therapies for Cushing Disease: Improving Medication Adherence
Susan Cornell, PharmD, CDE, reviews medication adherence in relation to Cushing disease.
Susan Cornell, PharmD, CDE
  • Print